Ekici, B. Et Al. 2021. Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR). Turk Kardiyoloji Dernegi Arsivi , vol.49, no.5 , 357-367.

Ekici, B., Yaman, M., KÜÇÜK, M., Dereli, S., Yenerçaǧ, M., YİĞİT, Z., ... Memduh Baş, M.(2021). Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR). Turk Kardiyoloji Dernegi Arsivi , vol.49, no.5, 357-367.

Ekici, BERKAY Et Al. "Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)," Turk Kardiyoloji Dernegi Arsivi , vol.49, no.5, 357-367, 2021

Ekici, BERKAY Et Al. "Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)." Turk Kardiyoloji Dernegi Arsivi , vol.49, no.5, pp.357-367, 2021

Ekici, B. Et Al. (2021) . "Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)." Turk Kardiyoloji Dernegi Arsivi , vol.49, no.5, pp.357-367.

@article{article, author={BERKAY EKİCİ Et Al. }, title={Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)}, journal={Turk Kardiyoloji Dernegi Arsivi}, year=2021, pages={357-367} }